KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma

OBJECTIVES: There is no molecular biomarker available in the clinical practice to assess the prognosis of advanced pancreatic carcinoma. This multicenter prospective study aimed to investigate the role of KRAS mutation subtypes within the primary tumor to determine the prognosis of advanced pancreat...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Transl Gastroenterol
Huvudupphovsmän: Bournet, Barbara, Muscari, Fabrice, Buscail, Camille, Assenat, Eric, Barthet, Marc, Hammel, Pascal, Selves, Janick, Guimbaud, Rosine, Cordelier, Pierre, Buscail, Louis
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2016
Ämnen:
Original Contributions
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4822095/
https://ncbi.nlm.nih.gov/pubmed/27010960
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ctg.2016.18
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk